Screener
Krystal Biotech, Inc. KRYS Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
| (in thousands, except par value) | March 31,2026 | December 31,2025 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $501,313 | $496,304 |
| Short-term investments | 322,092 | 331,487 |
| Accounts receivable, net | 127,022 | 127,425 |
| Inventory | 42,646 | 40,475 |
| Prepaid taxes | 10,642 | 14,006 |
| Prepaid expenses and other current assets | 16,026 | 14,905 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Krystal Biotech, Inc.'s short-term investments?
- Krystal Biotech, Inc. (KRYS) reported short-term investments of $322.09M in Q1 2026.
- How has Krystal Biotech, Inc.'s short-term investments changed year-over-year?
- Krystal Biotech, Inc.'s short-term investments increased by 4.5% year-over-year, from $308.08M to $322.09M.
- What is the long-term trend for Krystal Biotech, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s short-term investments has grown at a 156.4% compound annual growth rate (CAGR), from $2.99M to $331.49M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Krystal Biotech, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude